Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracoronary Nitroprusside for the Prevention of the No-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. A Randomized, Double Blind, Placebo-Controlled Clinical Trial

NCT00128791 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT00128791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00128791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracoronary Nitroprusside for the Prevention of the No-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. A Randomized, Double Blind, Placebo-Controlled Clinical Trial
Lead sponsor
Soroka University Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2003
Completion date
April 30, 2005
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction